<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE book-part-wrapper PUBLIC "-//NLM//DTD BITS Book Interchange DTD v2.0 20151225//EN" "http://jats.nlm.nih.gov/extensions/bits/2.0/BITS-book2.dtd">
<book-part-wrapper id="article-28987" content-type="chapter" dtd-version="2.0">
  <book-meta>
    <book-id book-id-type="pmcid">statpearls</book-id>
    <book-title-group>
      <book-title>StatPearls</book-title>
    </book-title-group>
    <pub-date publication-format="electronic" date-type="pubr">
      <month>01</month>
      <year>2024</year>
    </pub-date>
    <publisher>
      <publisher-name>StatPearls Publishing</publisher-name>
      <publisher-loc>Treasure Island (FL)</publisher-loc>
    </publisher>
    <permissions>
      <copyright-statement>Copyright &#x000a9; 2024, StatPearls Publishing LLC</copyright-statement>
      <license xmlns:xlink="http://www.w3.org/1999/xlink" license-type="open-access" xlink:href="https://creativecommons.org/licenses/by-nc-nd/4.0/">
        <license-p>
This book is distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International (CC BY-NC-ND 4.0)
(<ext-link xlink:href="https://creativecommons.org/licenses/by-nc-nd/4.0/" ext-link-type="uri">
http://creativecommons.org/licenses/by-nc-nd/4.0/
</ext-link>), which permits others to distribute the work, provided that the article is not altered or used commercially. You are not required to obtain permission to distribute this article, provided that you credit the author and journal.
</license-p>
      </license>
    </permissions>
    <custom-meta-group>
      <custom-meta>
        <meta-name>books-source-type</meta-name>
        <meta-value>Database</meta-value>
      </custom-meta>
    </custom-meta-group>
    <notes notes-type="disclaimer">
      <p>The intent of StatPearls review books and articles is to identify knowledge deficits and assist you in the learning process. Review books and articles are not intended to be a source of the knowledge base of medicine. The authors and editors do not warrant the information is complete or accurate. The reader is encouraged to verify content and questions in several references. All drug indications and dosages should be verified before administration.</p>
      <p>The authors and editors would like to extend special thanks to Erin Hughes and Gerson Rubio for their editorial support.</p>
    </notes>
  </book-meta>
  <book-part book-part-type="chapter">
    <book-part-meta>
      <title-group>
        <title>Short-Lasting Unilateral Neuralgiform Headache</title>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Al Khalili</surname>
            <given-names>Yasir</given-names>
          </name>
          <aff>Virginia Commonwealth University</aff>
        </contrib>
      </contrib-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Veerapaneni</surname>
            <given-names>Karthika Durga</given-names>
          </name>
          <aff>University of Arkansas Medical Sciences</aff>
        </contrib>
      </contrib-group>
      <author-notes>
        <fn fn-type="COI-statement">
          <p><bold>Disclosure: </bold>Yasir Al Khalili declares no relevant financial relationships with ineligible companies.</p>
        </fn>
        <fn fn-type="COI-statement">
          <p><bold>Disclosure: </bold>Karthika Durga Veerapaneni declares no relevant financial relationships with ineligible companies.</p>
        </fn>
      </author-notes>
      <pub-history>
        <date date-type="updated">
          <day>29</day>
          <month>5</month>
          <year>2023</year>
        </date>
      </pub-history>
    </book-part-meta>
    <body>
      <sec id="article-28987.s1" sec-type="Continuing Education Activity">
        <title>Continuing Education Activity</title>
        <p>Short-lasting unilateral neuralgiform headache is a rare primary headache disorder that comes with infrequent attacks that last seconds. The pain can be severe stabbing on one side of the face. The criteria to diagnose this condition has been updated recently. Secondary causes must be ruled out, some of which could be life-threatening. This activity reviews the signs, symptoms, evaluation, treatment, and management of short-lasting unilateral neuralgiform headaches and highlights the role of the interprofessional team in the care of patients with this condition.</p>
        <p>
<bold>Objectives:</bold>
<list list-type="bullet"><list-item><p>Identify the etiology of short-lasting unilateral neuralgiform headache.</p></list-item><list-item><p>Explain the common physical exam findings associated with short-lasting unilateral neuralgiform headache.</p></list-item><list-item><p>Review management options available for short-lasting unilateral neuralgiform headache.</p></list-item><list-item><p>Summarize the importance of communication amongst the interprofessional team to and enhance the delivery of treatment for patients with short-lasting unilateral neuralgiform headache.</p></list-item></list>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.statpearls.com/account/trialuserreg/?articleid=28987&#x00026;utm_source=pubmed&#x00026;utm_campaign=reviews&#x00026;utm_content=28987">Access free multiple choice questions on this topic.</ext-link>
</p>
      </sec>
      <sec id="article-28987.s2" sec-type="pubmed-excerpt">
        <title>Introduction</title>
        <p>Headache and pain disorders constitute the leading causes of morbidity and disability in the world.<xref ref-type="bibr" rid="article-28987.r1">[1]</xref><xref ref-type="bibr" rid="article-28987.r2">[2]</xref>&#x000a0;There are many types of headache disorders that have been categorized by the International Classification of Headache Disorders. Short-lasting unilateral neuralgiform headache is a type of trigeminal autonomic cephalalgia and occurs in a unilateral fashion that&#x000a0;presents with some autonomic features. There are two kinds of unilateral neuralgiform headache:&#x000a0;1. Short-lasting unilateral neuralgiform headache attacks with conjunctival injection and tearing (SUNCT)&#x000a0;2. Short-lasting unilateral neuralgiform headache with autonomic symptoms (SUNA) which will be described in detail in this article.<xref ref-type="bibr" rid="article-28987.r3">[3]</xref></p>
        <p>Although relatively rare, these headache attacks are easy to recognize, given their constellation of signs and symptoms. SUNCT and SUNA classify as part of the trigeminal autonomic cephalalgias (TACs). They are considered to be the headache with the most frequent attacks that range from 2 to 600 times daily, but averaging &#x0003c; 100/day. The attacks are usually of moderate to severe intensity and can have throbbing pain or the pain can be sharp at times.</p>
      </sec>
      <sec id="article-28987.s3" sec-type="Etiology">
        <title>Etiology</title>
        <p>A stimulus to the trigeminal nerve is required to start the cascade. The stimulus could be simple or a noxious one. Once the trigeminal ganglion is activated, it projects impulses to the trigeminal-cervical complex, which is composed of C1/C2 dorsal horns and the trigeminal nucleus caudalis (TNC).<xref ref-type="bibr" rid="article-28987.r4">[4]</xref> From the trigeminal-cervical complex, neurons project to the superior salivary nucleus (SSN) in the pons, which sends parasympathetic fibers that synapse on the sphenopalatine ganglion. After synapsing at the ganglion, post-ganglionic parasympathetic fibers innervate the lacrimal gland and the nasal mucosa and palate.<xref ref-type="bibr" rid="article-28987.r5">[5]</xref></p>
      </sec>
      <sec id="article-28987.s4" sec-type="Epidemiology">
        <title>Epidemiology</title>
        <p>The estimated prevalence of SUNCT and SUNA is 6.6 per 100,000, and the annual incidence to be 1.2 per 100,000.<xref ref-type="bibr" rid="article-28987.r6">[6]</xref>&#x000a0;The age of onset typically is between 35 and 65 with a mean age of 48. There is a male predominance in SUNCT, and a female predominance in SUNA, similar to trigeminal neuralgia.<xref ref-type="bibr" rid="article-28987.r7">[7]</xref>&#x000a0;There has been one recently published case report of a familial SUNCT syndrome.<xref ref-type="bibr" rid="article-28987.r8">[8]</xref></p>
      </sec>
      <sec id="article-28987.s5" sec-type="Pathophysiology">
        <title>Pathophysiology</title>
        <p>The exact pathophysiology of SUNCT and SUNA remains unknown. Hypothalamic dysfunction has been reported in current research that leads to the overproduction of nociceptive orexin B that results in the trigeminal-hypothalamic tract, which activates the pain pathway.<xref ref-type="bibr" rid="article-28987.r9">[9]</xref> There is also a secondary activation of cortical areas that occurs after the activation of the trigeminal-cervical complex, and this leads to the severe pain associated with this SUNCT and SUNA.<xref ref-type="bibr" rid="article-28987.r10">[10]</xref><xref ref-type="bibr" rid="article-28987.r11">[11]</xref><xref ref-type="bibr" rid="article-28987.r12">[12]</xref>&#x000a0;Patients who underwent deep brain stimulation to the ventral tegmental area (VTA) ipsilateral to the side of the attacks showed about 80% improvement in symptoms; this finding supports the involvement of VTA in the pathophysiology of SUNCT and SUNA.<xref ref-type="bibr" rid="article-28987.r13">[13]</xref></p>
      </sec>
      <sec id="article-28987.s6" sec-type="History and Physical">
        <title>History and Physical</title>
        <p>Pain in short-lasting unilateral neuralgiform headache is generally in the V1 distribution and can be described as sharp, stabbing, burning, or electrical shocks. Patients must report at least 20 attacks that fulfill the criteria for short-lasting unilateral neuralgiform headache. Attacks must be of moderate to severe pain intensity lasting 1-600 seconds with the orbital, supraorbital, or temporal distribution. These attacks must also be associated with at least one of the following autonomic symptoms: conjunctival injection, stuffy nose, tearing, rhinorrhea, eyelid swelling, increased sweating in the head and neck regions, or redness, ear discomfort, or miosis/ptosis.</p>
        <p>Similar to trigeminal neuralgia, SUNCT and SUNA can also be triggered by external stimuli. Common triggers include any irritation of the trigeminal nerve such as chewing, touching the face, brushing teeth, temperature, or even loud noise. They are differentiated from trigeminal neuralgia by the presence of cranial autonomic symptoms. Although migraine and other types of facial pain can stimulate the parasympathetic ganglion and produce some autonomic symptoms, they will not be as pronounced as the ones with SUNCT and SUNA.</p>
      </sec>
      <sec id="article-28987.s7" sec-type="Evaluation">
        <title>Evaluation</title>
        <p>Because SUNCT/SUNA can be secondary or symptomatic of underlying structural pathology, including pituitary, posterior fossa, or local lesions, a brain magnetic resonance imaging (MRI) with pituitary views and blood tests for pituitary function must be the minimal work-up for SUNCT/SUNA.</p>
        <p>However, the diagnosis is mostly clinical and is defined by the International Classification of Headache Disorders 3rd edition by the following diagnostic criteria.<xref ref-type="bibr" rid="article-28987.r3">[3]</xref></p>
        <p>A) Have had a minimum of 20 headache episodes that fulfill the criteria below</p>
        <p>B) Headache is at least of moderate-intensity in the orbital or temporal area on one side and lasts more than one second but less than 600 seconds.</p>
        <p>C) Must have one of the below symptoms on the same side as the headache</p>
        <p>1.&#x000a0;Tearing and redness of the eyes&#x000a0;2.&#x000a0;Stuffy nose or runny nose3. Eyelid&#x000a0;swelling on the same side as the headache&#x000a0;4. Sweating of head and neck area&#x000a0;5.&#x000a0;Redness of head and neck area&#x000a0;6.&#x000a0;Ear fullness and discomfort&#x000a0;7.&#x000a0;Droopy eyelid or pinpoint pupil&#x000a0;</p>
        <p>D) At least one attack per day when the disease is active</p>
        <p>These headache attacks occur very frequently when the disease is active. SUNCT and SUNA tend to have some associations with seasons.</p>
      </sec>
      <sec id="article-28987.s8" sec-type="Treatment / Management">
        <title>Treatment / Management</title>
        <p>There are three categories of treatment for trigeminal autonomic cephalalgia, including SUNCT and SUNA:&#x000a0;acute, preventive, and&#x000a0;bridge therapies.</p>
        <p>
<bold>Short Term Prevention</bold>
</p>
        <p>A trial of intravenous lidocaine reported some relief in patients with SUNCT and SUNA.<xref ref-type="bibr" rid="article-28987.r14">[14]</xref>&#x000a0;This requires cardiac and blood&#x000a0;pressure monitoring and, therefore, must be given in an intensive care unit (ICU)&#x000a0;or other inpatient monitored setting. The dose range is 1.3 mg/kg per hour&#x000a0;to 3.3 mg/kg per hour.&#x000a0;</p>
        <p>
<bold>Long Term Prevention</bold>
</p>
        <p>In many studies, lamotrigine has shown good results as first-line therapy for these disorders, with up to 80% of patients reporting improvement. Effective daily&#x000a0;doses range from 100 mg to 400 mg.<xref ref-type="bibr" rid="article-28987.r15">[15]</xref><xref ref-type="bibr" rid="article-28987.r16">[16]</xref><xref ref-type="bibr" rid="article-28987.r17">[17]</xref>&#x000a0;Carbamazepine and oxcarbazepine can be used as well, effective in doses up to 900 mg/day.<xref ref-type="bibr" rid="article-28987.r18">[18]</xref>&#x000a0;Topiramate has been used with good results and gabapentin (600 mg&#x000a0;per day to 3600 mg per day) has also&#x000a0;shown reported benefits.</p>
        <p>
<bold>Non-pharmacological Interventions</bold>
</p>
        <p>1) Greater occipital nerve block has shown some benefits.<xref ref-type="bibr" rid="article-28987.r19">[19]</xref></p>
        <p>2) Peripheral nerve blocks, including infra and supraorbital nerve blocks, also have shown benefit in previous studies.<xref ref-type="bibr" rid="article-28987.r19">[19]</xref></p>
        <p>3) Peripheral nerve stimulation of the occipital nerve has shown good results.<xref ref-type="bibr" rid="article-28987.r20">[20]</xref><xref ref-type="bibr" rid="article-28987.r21">[21]</xref><xref ref-type="bibr" rid="article-28987.r22">[22]</xref></p>
        <p>The lack of response to indomethacin and the response to intravenous lidocaine, are useful in diagnostic and therapeutic terms.<xref ref-type="bibr" rid="article-28987.r23">[23]</xref></p>
      </sec>
      <sec id="article-28987.s9" sec-type="Differential Diagnosis">
        <title>Differential Diagnosis</title>
        <list list-type="bullet">
          <list-item>
            <p>Other trigeminal autonomic cephalalgias</p>
          </list-item>
          <list-item>
            <p>Cluster headache</p>
          </list-item>
          <list-item>
            <p>Paroxysmal hemicrania</p>
          </list-item>
          <list-item>
            <p>Idiopathic chronic facial pain syndrome</p>
          </list-item>
          <list-item>
            <p>Atypical migraine&#x000a0;</p>
          </list-item>
          <list-item>
            <p>Hemicrania continua</p>
          </list-item>
          <list-item>
            <p>Trigeminal neuralgia</p>
          </list-item>
          <list-item>
            <p>Retinal migraine headache<xref ref-type="bibr" rid="article-28987.r24">[24]</xref></p>
          </list-item>
        </list>
      </sec>
      <sec id="article-28987.s10" sec-type="Prognosis">
        <title>Prognosis</title>
        <p>The natural history of SUNCT is not clear because of its rarity.&#x000a0;However, patients with SUNCT and SUNA have been known to have their condition for up to 46 years.<xref ref-type="bibr" rid="article-28987.r14">[14]</xref>&#x000a0;There is no correlation with mortality, and the disease is not fatal.&#x000a0;Prognosis at present is improving, as more treatment strategies become available.</p>
      </sec>
      <sec id="article-28987.s11" sec-type="Complications">
        <title>Complications</title>
        <p>Syndrome itself does not have any long-term neurological sequelae/complications. Most individuals present as normal between attacks.&#x000a0;The social and economic burden of SUNCT is unknown.</p>
      </sec>
      <sec id="article-28987.s12" sec-type="Deterrence and Patient Education">
        <title>Deterrence and Patient Education</title>
        <p>There are no identified risk factors and, thus, no known prevention for SUNCT syndrome.&#x000a0;In some patients, the background interictal pain in SUNCT may be attributable to migrainous biology and an analgesic overuse syndrome. Thus patients need to be educated about analgesic medication overuse. Overuse of medication can worsen this condition by increasing the frequency of attacks and severity.</p>
      </sec>
      <sec id="article-28987.s13" sec-type="Enhancing Healthcare Team Outcomes ">
        <title>Enhancing Healthcare Team Outcomes </title>
        <p>The diagnosis of SUNCT and SUNA is vital as many differential diagnoses are very similar. History taking is an essential step in the evaluation of these patients. Also, proper workup to rule out all secondary causes of facial pain like a vascular loop near the trigeminal nerve is essential. All members of the healthcare team&#x000a0;should be familiar with this condition as it is not very common, but they do occur in the real world and must be well managed.</p>
        <p>An interprofessional approach is necessary for the management of SUNCT, which includes the primary clinician, neurologist, nursing staff, and the pharmacy. A prompt referral is necessary from the&#x000a0;primary clinician to a neurologist for early diagnosis and management of this condition because of its debilitating nature. This article summarizes vital features in recognizing this condition, whether it is in the emergency department, primary office visit, or on the neurology wards. Although it is not a very common condition, it could present as a very serious possibility if not adequately investigated; therefore, this educational activity could help many professions to understand and co-manage SUNCT/SUNA.</p>
      </sec>
      <sec id="article-28987.s14">
        <title>Review Questions</title>
        <list list-type="bullet">
          <list-item>
            <p>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.statpearls.com/account/trialuserreg/?articleid=28987&#x00026;utm_source=pubmed&#x00026;utm_campaign=reviews&#x00026;utm_content=28987">Access free multiple choice questions on this topic.</ext-link>
</p>
          </list-item>
          <list-item>
            <p>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://mdsearchlight.com/migraine-headaches/short-lasting-unilateral-neuralgiform-headache/?utm_source=pubmedlink&#x00026;utm_campaign=MDS&#x00026;utm_content=28987">Click here for a simplified version.</ext-link>
</p>
          </list-item>
          <list-item>
            <p>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.statpearls.com/articlelibrary/commentarticle/28987/?utm_source=pubmed&#x00026;utm_campaign=comments&#x00026;utm_content=28987">Comment on this article.</ext-link>
</p>
          </list-item>
        </list>
      </sec>
    </body>
    <back>
      <ref-list id="article-28987.s15">
        <title>References</title>
        <ref id="article-28987.r1">
          <label>1</label>
          <element-citation publication-type="journal">
            <collab>GBD 2016 Disease and Injury Incidence and Prevalence Collaborators</collab>
            <article-title>Global, regional, and national incidence, prevalence, and years lived with disability for 328 diseases and injuries for 195 countries, 1990-2016: a systematic analysis for the Global Burden of Disease Study 2016.</article-title>
            <source>Lancet</source>
            <year>2017</year>
            <month>Sep</month>
            <day>16</day>
            <volume>390</volume>
            <issue>10100</issue>
            <fpage>1211</fpage>
            <page-range>1211-1259</page-range>
            <pub-id pub-id-type="pmid">28919117</pub-id>
          </element-citation>
        </ref>
        <ref id="article-28987.r2">
          <label>2</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Jain</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Malinowski</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Chopra</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Varshney</surname>
                <given-names>V</given-names>
              </name>
              <name>
                <surname>Deer</surname>
                <given-names>TR</given-names>
              </name>
            </person-group>
            <article-title>Intrathecal drug delivery for pain management: recent advances and future developments.</article-title>
            <source>Expert Opin Drug Deliv</source>
            <year>2019</year>
            <month>Aug</month>
            <volume>16</volume>
            <issue>8</issue>
            <fpage>815</fpage>
            <page-range>815-822</page-range>
            <pub-id pub-id-type="pmid">31305165</pub-id>
          </element-citation>
        </ref>
        <ref id="article-28987.r3">
          <label>3</label>
          <element-citation publication-type="journal">
            <article-title>Headache Classification Committee of the International Headache Society (IHS) The International Classification of Headache Disorders, 3rd edition.</article-title>
            <source>Cephalalgia</source>
            <year>2018</year>
            <month>Jan</month>
            <volume>38</volume>
            <issue>1</issue>
            <fpage>1</fpage>
            <page-range>1-211</page-range>
            <pub-id pub-id-type="pmid">29368949</pub-id>
          </element-citation>
        </ref>
        <ref id="article-28987.r4">
          <label>4</label>
          <element-citation publication-type="book">
            <person-group person-group-type="author">
              <name>
                <surname>Mathews</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Jain</surname>
                <given-names>S</given-names>
              </name>
            </person-group>
            <chapter-title>Anatomy, Head and Neck, Cricoid Cartilage</chapter-title>
            <source>StatPearls [Internet]</source>
            <publisher-name>StatPearls Publishing</publisher-name>
            <publisher-loc>Treasure Island (FL)</publisher-loc>
            <year>2023</year>
            <month>8</month>
            <day>7</day>
            <pub-id pub-id-type="pmid">30969643</pub-id>
          </element-citation>
        </ref>
        <ref id="article-28987.r5">
          <label>5</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Gunesli</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Tufan</surname>
                <given-names>K</given-names>
              </name>
            </person-group>
            <article-title>Significance of the Cerebellopontine Cistern Cross-Sectional Area and Trigeminal Nerve Anatomy in Trigeminal Neuralgia: An Anatomical Study Using Magnetic Resonance Imaging.</article-title>
            <source>Turk Neurosurg</source>
            <year>2020</year>
            <volume>30</volume>
            <issue>2</issue>
            <fpage>271</fpage>
            <page-range>271-276</page-range>
            <pub-id pub-id-type="pmid">32091126</pub-id>
          </element-citation>
        </ref>
        <ref id="article-28987.r6">
          <label>6</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Williams</surname>
                <given-names>MH</given-names>
              </name>
              <name>
                <surname>Broadley</surname>
                <given-names>SA</given-names>
              </name>
            </person-group>
            <article-title>SUNCT and SUNA: clinical features and medical treatment.</article-title>
            <source>J Clin Neurosci</source>
            <year>2008</year>
            <month>May</month>
            <volume>15</volume>
            <issue>5</issue>
            <fpage>526</fpage>
            <page-range>526-34</page-range>
            <pub-id pub-id-type="pmid">18325769</pub-id>
          </element-citation>
        </ref>
        <ref id="article-28987.r7">
          <label>7</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Favoni</surname>
                <given-names>V</given-names>
              </name>
              <name>
                <surname>Grimaldi</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Pierangeli</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Cortelli</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Cevoli</surname>
                <given-names>S</given-names>
              </name>
            </person-group>
            <article-title>SUNCT/SUNA and neurovascular compression: new cases and critical literature review.</article-title>
            <source>Cephalalgia</source>
            <year>2013</year>
            <month>Dec</month>
            <volume>33</volume>
            <issue>16</issue>
            <fpage>1337</fpage>
            <page-range>1337-48</page-range>
            <pub-id pub-id-type="pmid">23800827</pub-id>
          </element-citation>
        </ref>
        <ref id="article-28987.r8">
          <label>8</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Martins</surname>
                <given-names>IP</given-names>
              </name>
              <name>
                <surname>Viana</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Lobo</surname>
                <given-names>PP</given-names>
              </name>
            </person-group>
            <article-title>Familial SUNCT in mother and son.</article-title>
            <source>Cephalalgia</source>
            <year>2016</year>
            <month>Sep</month>
            <volume>36</volume>
            <issue>10</issue>
            <fpage>993</fpage>
            <page-range>993-7</page-range>
            <pub-id pub-id-type="pmid">26553730</pub-id>
          </element-citation>
        </ref>
        <ref id="article-28987.r9">
          <label>9</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Arca</surname>
                <given-names>KN</given-names>
              </name>
              <name>
                <surname>Halker Singh</surname>
                <given-names>RB</given-names>
              </name>
            </person-group>
            <article-title>SUNCT and SUNA: an Update and Review.</article-title>
            <source>Curr Pain Headache Rep</source>
            <year>2018</year>
            <month>Jun</month>
            <day>21</day>
            <volume>22</volume>
            <issue>8</issue>
            <fpage>56</fpage>
            <pub-id pub-id-type="pmid">29931416</pub-id>
          </element-citation>
        </ref>
        <ref id="article-28987.r10">
          <label>10</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Ossipov</surname>
                <given-names>MH</given-names>
              </name>
              <name>
                <surname>Raffa</surname>
                <given-names>RB</given-names>
              </name>
              <name>
                <surname>Pergolizzi</surname>
                <given-names>JV</given-names>
              </name>
            </person-group>
            <article-title>Galcanezumab: a humanized monoclonal antibody for the prevention of migraine and cluster headache.</article-title>
            <source>Drugs Today (Barc)</source>
            <year>2020</year>
            <month>Jan</month>
            <volume>56</volume>
            <issue>1</issue>
            <fpage>5</fpage>
            <page-range>5-19</page-range>
            <pub-id pub-id-type="pmid">32055802</pub-id>
          </element-citation>
        </ref>
        <ref id="article-28987.r11">
          <label>11</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Goadsby</surname>
                <given-names>PJ</given-names>
              </name>
            </person-group>
            <article-title>Pathophysiology of cluster headache: a trigeminal autonomic cephalgia.</article-title>
            <source>Lancet Neurol</source>
            <year>2002</year>
            <month>Aug</month>
            <volume>1</volume>
            <issue>4</issue>
            <fpage>251</fpage>
            <page-range>251-7</page-range>
            <pub-id pub-id-type="pmid">12849458</pub-id>
          </element-citation>
        </ref>
        <ref id="article-28987.r12">
          <label>12</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Jain</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Yuan</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Spare</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>Silberstein</surname>
                <given-names>SD</given-names>
              </name>
            </person-group>
            <article-title>Erenumab in the treatment of migraine.</article-title>
            <source>Pain Manag</source>
            <year>2018</year>
            <month>Nov</month>
            <day>01</day>
            <volume>8</volume>
            <issue>6</issue>
            <fpage>415</fpage>
            <page-range>415-426</page-range>
            <pub-id pub-id-type="pmid">30235976</pub-id>
          </element-citation>
        </ref>
        <ref id="article-28987.r13">
          <label>13</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Miller</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Akram</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Lagrata</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Hariz</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Zrinzo</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Matharu</surname>
                <given-names>M</given-names>
              </name>
            </person-group>
            <article-title>Ventral tegmental area deep brain stimulation in refractory short-lasting unilateral neuralgiform headache attacks.</article-title>
            <source>Brain</source>
            <year>2016</year>
            <month>Oct</month>
            <volume>139</volume>
            <issue>Pt 10</issue>
            <fpage>2631</fpage>
            <page-range>2631-2640</page-range>
            <pub-id pub-id-type="pmid">27524793</pub-id>
          </element-citation>
        </ref>
        <ref id="article-28987.r14">
          <label>14</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Cohen</surname>
                <given-names>AS</given-names>
              </name>
              <name>
                <surname>Matharu</surname>
                <given-names>MS</given-names>
              </name>
              <name>
                <surname>Goadsby</surname>
                <given-names>PJ</given-names>
              </name>
            </person-group>
            <article-title>Short-lasting unilateral neuralgiform headache attacks with conjunctival injection and tearing (SUNCT) or cranial autonomic features (SUNA)--a prospective clinical study of SUNCT and SUNA.</article-title>
            <source>Brain</source>
            <year>2006</year>
            <month>Oct</month>
            <volume>129</volume>
            <issue>Pt 10</issue>
            <fpage>2746</fpage>
            <page-range>2746-60</page-range>
            <pub-id pub-id-type="pmid">16905753</pub-id>
          </element-citation>
        </ref>
        <ref id="article-28987.r15">
          <label>15</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Gutierrez-Garcia</surname>
                <given-names>JM</given-names>
              </name>
            </person-group>
            <article-title>SUNCT syndrome responsive to lamotrigine.</article-title>
            <source>Headache</source>
            <year>2002</year>
            <month>Sep</month>
            <volume>42</volume>
            <issue>8</issue>
            <fpage>823</fpage>
            <page-range>823-5</page-range>
            <pub-id pub-id-type="pmid">12390648</pub-id>
          </element-citation>
        </ref>
        <ref id="article-28987.r16">
          <label>16</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Weng</surname>
                <given-names>HY</given-names>
              </name>
              <name>
                <surname>Cohen</surname>
                <given-names>AS</given-names>
              </name>
              <name>
                <surname>Schankin</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Goadsby</surname>
                <given-names>PJ</given-names>
              </name>
            </person-group>
            <article-title>Phenotypic and treatment outcome data on SUNCT and SUNA, including a randomised placebo-controlled trial.</article-title>
            <source>Cephalalgia</source>
            <year>2018</year>
            <month>Aug</month>
            <volume>38</volume>
            <issue>9</issue>
            <fpage>1554</fpage>
            <page-range>1554-1563</page-range>
            <pub-id pub-id-type="pmid">29096522</pub-id>
          </element-citation>
        </ref>
        <ref id="article-28987.r17">
          <label>17</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Rossi</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Cesarino</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Faroni</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Malpezzi</surname>
                <given-names>MG</given-names>
              </name>
              <name>
                <surname>Sandrini</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Nappi</surname>
                <given-names>G</given-names>
              </name>
            </person-group>
            <article-title>SUNCT syndrome successfully treated with topiramate: case reports.</article-title>
            <source>Cephalalgia</source>
            <year>2003</year>
            <month>Dec</month>
            <volume>23</volume>
            <issue>10</issue>
            <fpage>998</fpage>
            <page-range>998-1000</page-range>
            <pub-id pub-id-type="pmid">14984234</pub-id>
          </element-citation>
        </ref>
        <ref id="article-28987.r18">
          <label>18</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Matharu</surname>
                <given-names>MS</given-names>
              </name>
              <name>
                <surname>Cohen</surname>
                <given-names>AS</given-names>
              </name>
              <name>
                <surname>Boes</surname>
                <given-names>CJ</given-names>
              </name>
              <name>
                <surname>Goadsby</surname>
                <given-names>PJ</given-names>
              </name>
            </person-group>
            <article-title>Short-lasting unilateral neuralgiform headache with conjunctival injection and tearing syndrome: a review.</article-title>
            <source>Curr Pain Headache Rep</source>
            <year>2003</year>
            <month>Aug</month>
            <volume>7</volume>
            <issue>4</issue>
            <fpage>308</fpage>
            <page-range>308-18</page-range>
            <pub-id pub-id-type="pmid">12828881</pub-id>
          </element-citation>
        </ref>
        <ref id="article-28987.r19">
          <label>19</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Pareja</surname>
                <given-names>JA</given-names>
              </name>
              <name>
                <surname>Kruszewski</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Sjaastad</surname>
                <given-names>O</given-names>
              </name>
            </person-group>
            <article-title>SUNCT syndrome: trials of drugs and anesthetic blockades.</article-title>
            <source>Headache</source>
            <year>1995</year>
            <month>Mar</month>
            <volume>35</volume>
            <issue>3</issue>
            <fpage>138</fpage>
            <page-range>138-42</page-range>
            <pub-id pub-id-type="pmid">7721573</pub-id>
          </element-citation>
        </ref>
        <ref id="article-28987.r20">
          <label>20</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Deer</surname>
                <given-names>TR</given-names>
              </name>
              <name>
                <surname>Jain</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Hunter</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Chakravarthy</surname>
                <given-names>K</given-names>
              </name>
            </person-group>
            <article-title>Neurostimulation for Intractable Chronic Pain.</article-title>
            <source>Brain Sci</source>
            <year>2019</year>
            <month>Jan</month>
            <day>24</day>
            <volume>9</volume>
            <issue>2</issue>
            <pub-id pub-id-type="pmid">30682776</pub-id>
          </element-citation>
        </ref>
        <ref id="article-28987.r21">
          <label>21</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Deer</surname>
                <given-names>TR</given-names>
              </name>
              <name>
                <surname>Grider</surname>
                <given-names>JS</given-names>
              </name>
              <name>
                <surname>Lamer</surname>
                <given-names>TJ</given-names>
              </name>
              <name>
                <surname>Pope</surname>
                <given-names>JE</given-names>
              </name>
              <name>
                <surname>Falowski</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Hunter</surname>
                <given-names>CW</given-names>
              </name>
              <name>
                <surname>Provenzano</surname>
                <given-names>DA</given-names>
              </name>
              <name>
                <surname>Slavin</surname>
                <given-names>KV</given-names>
              </name>
              <name>
                <surname>Russo</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Carayannopoulos</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Shah</surname>
                <given-names>JM</given-names>
              </name>
              <name>
                <surname>Harned</surname>
                <given-names>ME</given-names>
              </name>
              <name>
                <surname>Hagedorn</surname>
                <given-names>JM</given-names>
              </name>
              <name>
                <surname>Bolash</surname>
                <given-names>RB</given-names>
              </name>
              <name>
                <surname>Arle</surname>
                <given-names>JE</given-names>
              </name>
              <name>
                <surname>Kapural</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Amirdelfan</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Jain</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Liem</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Carlson</surname>
                <given-names>JD</given-names>
              </name>
              <name>
                <surname>Malinowski</surname>
                <given-names>MN</given-names>
              </name>
              <name>
                <surname>Bendel</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Yang</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Aiyer</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Valimahomed</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Antony</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Craig</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Fishman</surname>
                <given-names>MA</given-names>
              </name>
              <name>
                <surname>Al-Kaisy</surname>
                <given-names>AA</given-names>
              </name>
              <name>
                <surname>Christelis</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>Rosenquist</surname>
                <given-names>RW</given-names>
              </name>
              <name>
                <surname>Levy</surname>
                <given-names>RM</given-names>
              </name>
              <name>
                <surname>Mekhail</surname>
                <given-names>N</given-names>
              </name>
            </person-group>
            <article-title>A Systematic Literature Review of Spine Neurostimulation Therapies for the Treatment of Pain.</article-title>
            <source>Pain Med</source>
            <year>2020</year>
            <month>Nov</month>
            <day>07</day>
            <volume>21</volume>
            <issue>7</issue>
            <fpage>1421</fpage>
            <page-range>1421-1432</page-range>
            <pub-id pub-id-type="pmid">32034422</pub-id>
          </element-citation>
        </ref>
        <ref id="article-28987.r22">
          <label>22</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Jain</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Fishman</surname>
                <given-names>MA</given-names>
              </name>
              <name>
                <surname>Wu</surname>
                <given-names>C</given-names>
              </name>
            </person-group>
            <article-title>Significant cephalad lead migration with use of externally powered spinal cord stimulator.</article-title>
            <source>BMJ Case Rep</source>
            <year>2018</year>
            <month>Sep</month>
            <day>21</day>
            <volume>2018</volume>
            <pub-id pub-id-type="pmid">30244224</pub-id>
          </element-citation>
        </ref>
        <ref id="article-28987.r23">
          <label>23</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Cohen</surname>
                <given-names>AS</given-names>
              </name>
            </person-group>
            <article-title>Short-lasting unilateral neuralgiform headache attacks with conjunctival injection and tearing.</article-title>
            <source>Cephalalgia</source>
            <year>2007</year>
            <month>Jul</month>
            <volume>27</volume>
            <issue>7</issue>
            <fpage>824</fpage>
            <page-range>824-32</page-range>
            <pub-id pub-id-type="pmid">17598764</pub-id>
          </element-citation>
        </ref>
        <ref id="article-28987.r24">
          <label>24</label>
          <element-citation publication-type="book">
            <person-group person-group-type="author">
              <name>
                <surname>Al Khalili</surname>
                <given-names>Y</given-names>
              </name>
              <name>
                <surname>Jain</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>King</surname>
                <given-names>KC</given-names>
              </name>
            </person-group>
            <chapter-title>Retinal Migraine Headache</chapter-title>
            <source>StatPearls [Internet]</source>
            <publisher-name>StatPearls Publishing</publisher-name>
            <publisher-loc>Treasure Island (FL)</publisher-loc>
            <year>2023</year>
            <month>6</month>
            <day>26</day>
            <pub-id pub-id-type="pmid">29939547</pub-id>
          </element-citation>
        </ref>
      </ref-list>
    </back>
  </book-part>
</book-part-wrapper>
